Crystal structure of human cathepsin S
- PMID: 9655332
- PMCID: PMC2144034
- DOI: 10.1002/pro.5560070604
Crystal structure of human cathepsin S
Abstract
We have determined the 2.5 A structure (Rcryst = 20.5%, Rfree = 28.5%) of a complex between human cathepsin S and the potent, irreversible inhibitor 4-morpholinecarbonyl-Phe-hPhe-vinyl sulfone-phenyl. Noncrystallographic symmetry averaging and other density modification techniques were used to improve electron density maps which were nonoptimal due to systematically incomplete data. Methods that reduce the number of parameters were implemented for refinement. The refined structure shows cathepsin S to be similar to related cysteine proteases such as papain and cathepsins K and L. As expected, the covalently-bound inhibitor is attached to the enzyme at Cys 25, and enzyme binding subsites S3-S1' are occupied by the respective inhibitor substituents. A somewhat larger S2 pocket than what is found in similar enzymes is consistent with the broader specificity of cathepsin S at this site, while Lys 61 in the S3 site may offer opportunities for selective inhibition of this enzyme. The presence of Arg 137 in the S1' pocket, and proximal to Cys 25 may have implications not only for substrate specificity C-terminal to the scissile bond, but also for catalysis.
Similar articles
-
Specificity determinants of human cathepsin s revealed by crystal structures of complexes.Biochemistry. 2003 Mar 25;42(11):3203-13. doi: 10.1021/bi027308i. Biochemistry. 2003. PMID: 12641451
-
Peptide ketobenzoxazole inhibitors bound to cathepsin K.Biochemistry. 2003 Dec 30;42(51):15018-28. doi: 10.1021/bi035041x. Biochemistry. 2003. PMID: 14690410
-
Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.J Mol Biol. 2000 Jan 28;295(4):939-51. doi: 10.1006/jmbi.1999.3410. J Mol Biol. 2000. PMID: 10656802
-
Lysosomal cysteine proteases (cathepsins): promising drug targets.Acta Crystallogr D Biol Crystallogr. 2003 Feb;59(Pt 2):203-13. doi: 10.1107/s0907444902021479. Epub 2003 Jan 23. Acta Crystallogr D Biol Crystallogr. 2003. PMID: 12554931 Review.
-
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.Chembiochem. 2006 Oct;7(10):1525-35. doi: 10.1002/cbic.200600149. Chembiochem. 2006. PMID: 16921579 Review.
Cited by
-
In-silico and in-vitro screening of Asiatic acid and Asiaticoside A against Cathepsin S enzyme.BMC Pharmacol Toxicol. 2023 Nov 25;24(1):67. doi: 10.1186/s40360-023-00701-x. BMC Pharmacol Toxicol. 2023. PMID: 38007481 Free PMC article.
-
Proteolysis and antigen presentation by MHC class II molecules.Adv Immunol. 2002;80:71-114. doi: 10.1016/s0065-2776(02)80013-x. Adv Immunol. 2002. PMID: 12078484 Free PMC article. Review.
-
Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development.Pathophysiology. 2024 Sep 3;31(3):471-487. doi: 10.3390/pathophysiology31030035. Pathophysiology. 2024. PMID: 39311309 Free PMC article. Review.
-
Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.Biochimie. 2010 Nov;92(11):1618-24. doi: 10.1016/j.biochi.2010.04.023. Epub 2010 May 4. Biochimie. 2010. PMID: 20447439 Free PMC article.
-
The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group.Protein Sci. 2000 Nov;9(11):2218-24. doi: 10.1110/ps.9.11.2218. Protein Sci. 2000. PMID: 11152132 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials